Stock CNSP CNS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News CNS Pharmaceuticals, Inc.

Equities

CNSP

US18978H3003

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-14 pm EDT 		5-day change 1st Jan Change
2.79 USD -22.93% Intraday chart for CNS Pharmaceuticals, Inc. -44.75% -95.61%
Jun. 14 CNS Pharmaceuticals, Inc. announced that it expects to receive $1.3725 million in funding CI
Jun. 10 Sector Update: Health Care Stocks Advance Late Afternoon MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CNS Pharmaceuticals, Inc. announced that it expects to receive $1.3725 million in funding
CI
Sector Update: Health Care Stocks Advance Late Afternoon
MT
Top Midday Decliners
MT
CNS Pharmaceuticals Files Registration Statement for $9.2 Million Share, Warrant Offering -- Shares Fall
MT
CNS Pharmaceuticals Schedules 1-For-50 Reverse Stock Split This Week
MT
CNS Pharmaceuticals to Present at Alliance Global Partner's 2024 Healthcare Company Showcase
AQ
CNS Pharmaceuticals Reports First Quarter 2024 Financial Results
AQ
CNS Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
CNS Pharmaceuticals, Inc. Announces Committee Changes
CI
Transcript : CNS Pharmaceuticals, Inc. - Shareholder/Analyst Call
CNS Pharmaceuticals to Present at the LSX World Congress 2024
AQ
Transcript : CNS Pharmaceuticals, Inc. - Special Call
CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break, the CNSP Opportunity
AQ
CNS Pharmaceuticals to Present at Two Investor Conferences in April
AQ
CNS Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
CNS Pharmaceuticals, Inc. Approves the Appointments to its Board Committees
CI
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday on Caution Ahead of Fed Meeting, Tech Earnings
MT
CNS Pharmaceuticals Announces Pricing of $4.0 Million Public Offering
AQ
CNS Pharmaceuticals Prices $4 Million Offering; Shares Fall Pre-Bell
MT
Biotech Commercialization Leader, Amy Mahery, to Join CNS Pharmaceuticals Board of Directors
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CNSP Stock
  4. News CNS Pharmaceuticals, Inc.